(dp0
VLIFE
p1
F-1.0
sVRESPOND TO
p2
F1.0
sVAGE
p3
F1.0
sVTREATMENTS
p4
F1.0
sVTIME
p5
F1.0
sVIMMUNOPHENOTYPE
p6
F3.0
sVEFFICIENCY
p7
F1.0
sVCLUMPING
p8
F1.0
sVGROWING
p9
F-1.0
sVTO INTERACT WITH
p10
F1.0
sVINDUCED
p11
F5.0
sVTRANSCRIPTIONAL
p12
F3.0
sVCROWN
p13
F1.0
sVIS A
p14
F2.0
sVC-ERBB
p15
F1.0
sVCRITICAL
p16
F-1.0
sVCARCINOMA
p17
F2.0
sVCASES
p18
F1.0
sVPOST-TRANSLATIONAL MODIFICATIONS
p19
F3.0
sVAFFECTED
p20
F1.0
sVESOPHAGEAL SQUAMOUS CELL
p21
F1.0
sVNATURE
p22
F3.0
sVXPB
p23
F1.0
sVXPA
p24
F1.0
sVLARVAL DEVELOPMENT
p25
F1.0
sVSITES
p26
F3.0
sVXPD
p27
F1.0
sVCONCENTRATION OF
p28
F1.0
sVHEPATITIS B VIRUS X PROTEIN
p29
F1.0
sVDEEP VEIN
p30
F1.0
sVMEASURED
p31
F4.0
sVSEVERITY
p32
F-1.0
sVTUMOR
p33
F1.0
sVP89
p34
F1.0
sVHYDROXYBUTYRATE
p35
F1.0
sVREVIEW
p36
F-1.0
sVP80
p37
F2.0
sVNOT OBSERVED
p38
F1.0
sVORIENTED
p39
F1.0
sVVALUES
p40
F1.0
sVSEMEN PH
p41
F1.0
sVESTABLISHED
p42
F3.0
sVMUTANT
p43
F3.0
sVTSH
p44
F1.0
sVNORMAL
p45
F4.0
sVSPERMATOZOA MOTILITY
p46
F1.0
sVVOLUME
p47
F1.0
sVHEPATIC
p48
F3.0
sVT3 UPTAKE
p49
F1.0
sVCOMPARED
p50
F-1.0
sVPROBABILITY
p51
F-1.0
sVMODIFIED
p52
F3.0
sVCOMMON
p53
F1.0
sVRADIOSENSITIVITY
p54
F1.0
sVCRATAEGUS DOUGLASII
p55
F1.0
sVPKCS
p56
F1.0
sVTOTAL PROTEIN
p57
F1.0
sVSEQUENCE
p58
F3.0
sVLATERAL
p59
F1.0
sVLOSE
p60
F-1.0
sVANALYZER
p61
F1.0
sVVISUALIZED
p62
F-1.0
sVINDIVIDUAL
p63
F1.0
sVBITTER CHERRY
p64
F1.0
sVRESULT
p65
F1.0
sVSAMPLES
p66
F1.0
sVACTIVE
p67
F3.0
sVIMPROVED
p68
F1.0
sVNON
p69
F1.0
sVDNA-PKCS
p70
F1.0
sVFRUIT FLY
p71
F1.0
sVSTRUCTURE
p72
F1.0
sVMAD2
p73
F3.0
sVGOATS
p74
F1.0
sVMATCHED
p75
F1.0
sVFEATURES
p76
F3.0
sVORF3
p77
F3.0
sVLARVAL
p78
F1.0
sVDISPLACEMENT
p79
F1.0
sVLIFE CYCLES
p80
F-1.0
sVTUMOR SUPPRESSOR
p81
F1.0
sVTISSUE
p82
F1.0
sVPATHWAYS
p83
F1.0
sVAMPLITUDE
p84
F1.0
sVPERFORMANCE
p85
F1.0
sVHEPATITIS B VIRUS
p86
F1.0
sVPLANTS
p87
F-1.0
sVHORMONE
p88
F1.0
sVPATIENT
p89
F1.0
sVMETHODS
p90
F1.0
sVDROP
p91
F1.0
sVGLAND
p92
F1.0
sVDEHYDRATION
p93
F-1.0
sVREGULATED
p94
F1.0
sVDOSES
p95
F1.0
sVCANOPY
p96
F1.0
sVRESPONSE TO
p97
F2.0
sVHISTOLOGICAL
p98
F3.0
sVBODIES
p99
F3.0
sVLEFT
p100
F1.0
sVDIFFERENT
p101
F0.0
sVWEIGHT
p102
F2.0
sVPRESENCE
p103
F1.0
sVVASCULAR
p104
F1.0
sVSITE
p105
F3.0
sVSUMMARY
p106
F1.0
sVHOST
p107
F1.0
sVHEPATITIS B
p108
F1.0
sVBUFFALO
p109
F1.0
sVRADIOTHERAPY
p110
F1.0
sVSUPPRESSOR
p111
F1.0
sVACTIVATED
p112
F3.0
sVEARLY
p113
F1.0
sVWESTERN
p114
F1.0
sVAPOPTOSIS
p115
F2.0
sVSEASONS
p116
F1.0
sVSLIGHTLY
p117
F1.0
sVENDEMIC
p118
F1.0
sVADENOVIRUS TYPE
p119
F3.0
sVESTERIFIED FATTY ACIDS
p120
F1.0
sVRELATIONSHIP
p121
F1.0
sVFORESTS
p122
F1.0
sVAGGREGATION
p123
F3.0
sVFORMS
p124
F3.0
sVWEEKS
p125
F1.0
sVDATA
p126
F0.0
sVSTIMULATING
p127
F1.0
sVFROST DAMAGE
p128
F-1.0
sVINTAKE
p129
F1.0
sVDATA COLLECTION
p130
F1.0
sVPRUNUS
p131
F1.0
sVPARAMETERS
p132
F1.0
sVTREATMENT EFFICACY
p133
F1.0
sVLEVEL
p134
F3.0
sVBULLS
p135
F1.0
sVREPRESSION
p136
F1.0
sVVIRUS
p137
F1.0
sVRISK OF
p138
F-1.0
sVBLOOD
p139
F2.0
sVSP1
p140
F1.0
sVSPECIES
p141
F-1.0
sVP53
p142
F8.0
sVHEAD
p143
F2.0
sVLINEAR
p144
F1.0
sVDOWN-REGULATED
p145
F1.0
sVSTUDY
p146
F7.0
sVDNA BINDING ACTIVITY
p147
F1.0
sVPERIOD
p148
F0.0
sVIMPAIR
p149
F1.0
sVCOMPUTER
p150
F1.0
sVCELLULAR
p151
F1.0
sVFOUND
p152
F0.0
sVPML
p153
F3.0
sVRELATIVE
p154
F1.0
sVFLIES
p155
F1.0
sVREVIEW OF
p156
F-1.0
sVENVIRONMENT
p157
F-1.0
sVMAKE
p158
F1.0
sVBHB
p159
F1.0
sVOVERALL
p160
F3.0
sVNEGATIVE
p161
F1.0
sVBASAL
p162
F1.0
sVHEALTH
p163
F1.0
sVPERIODS
p164
F1.0
sVANIMAL
p165
F1.0
sVESTERIFIED
p166
F1.0
sVHER-2/NEU
p167
F1.0
sVIN BLOOD
p168
F1.0
sVDEVELOPMENTAL
p169
F1.0
sVECOSYSTEM
p170
F1.0
sVMCF7
p171
F3.0
sVHEPATITIS
p172
F1.0
sVPROGNOSIS
p173
F3.0
sVROUTINE
p174
F1.0
sVUSUALLY
p175
F1.0
sVFREE THYROXIN
p176
F1.0
sVPRE
p177
F1.0
sVCELL
p178
F8.0
sVSIMILAR
p179
F3.0
sVLATIN SQUARE
p180
F1.0
sVRAW
p181
F1.0
sVFUTURE
p182
F-1.0
sVABSENCE OF
p183
F3.0
sVTOTAL
p184
F2.0
sVCONDITIONS
p185
F0.0
sVTRIGLYCERIDES
p186
F1.0
sVINCREASED EXPRESSION
p187
F3.0
sVBROAD
p188
F1.0
sVENERGY
p189
F1.0
sVFREEZING
p190
F-1.0
sVDEEP VEIN THROMBOSIS
p191
F1.0
sVCOLLECTION
p192
F1.0
sVHIGH
p193
F0.0
sVEVALUATED
p194
F2.0
sVHUMAN ADENOVIRUS
p195
F3.0
sVRISK FACTOR
p196
F1.0
sVRETAINED
p197
F1.0
sVDAMAGE
p198
F-1.0
sVBINDING ACTIVITY
p199
F1.0
sVDETECTED
p200
F1.0
sVEFFECTS
p201
F1.0
sVSIGNIFICANT
p202
F2.0
sVOCCUR
p203
F-1.0
sVALBUMIN CONCENTRATION
p204
F1.0
sVPINUS CEMBRA
p205
F-1.0
sVINDIGENOUS
p206
F1.0
sVPEAK
p207
F1.0
sVCRATAEGUS
p208
F1.0
sVCOLD
p209
F1.0
sVPOPULATION
p210
F3.0
sVFEED EFFICIENCY
p211
F1.0
sVAVOIDANCE
p212
F-1.0
sVPREGNANT
p213
F1.0
sVORGANS
p214
F-1.0
sVHAWTHORN FRUIT
p215
F1.0
sVVELOCITY
p216
F1.0
sVSPERMATOZOA
p217
F1.0
sVFUNCTION
p218
F2.0
sVDOWN-REGULATION
p219
F1.0
sVEVERY TWO WEEKS
p220
F1.0
sVTEMPERATURE
p221
F1.0
sVTRANSCRIPTION
p222
F1.0
sVWASHINGTON
p223
F1.0
sVPOSSIBLE
p224
F-1.0
sVDAIRY
p225
F1.0
sVADAPTATION
p226
F1.0
sVRESPONSE TO ETOPOSIDE
p227
F3.0
sVPOST
p228
F3.0
sVAGRICULTURE
p229
F1.0
sVDAYS
p230
F1.0
sVSQUAMOUS
p231
F1.0
sVHEAD AND NECK
p232
F1.0
sVP21
p233
F3.0
sVFRUITS
p234
F-1.0
sVCLOSE TO
p235
F3.0
sVSWEET
p236
F1.0
sVHUMAN HEPATITIS B VIRUS
p237
F1.0
sVSP1 TRANSCRIPTION FACTOR
p238
F1.0
sVSPRING
p239
F-1.0
sVCOMPLICATIONS
p240
F1.0
sVTREATMENT
p241
F5.0
sVSMALL
p242
F-1.0
sVSEMEN QUALITY
p243
F1.0
sVALBUMIN
p244
F1.0
sVMANAGEMENT
p245
F1.0
sVAPOPTOTIC
p246
F3.0
sVLEFT LEG
p247
F1.0
sVWORK
p248
F3.0
sVINFECTED
p249
F3.0
sVMOTILITY
p250
F1.0
sVMASS
p251
F3.0
sVSHRINKING
p252
F3.0
sVPRESENT
p253
F4.0
sV2-3
p254
F1.0
sVPROGRESSIVE
p255
F1.0
sVMODELS
p256
F1.0
sVAFFECTS
p257
F1.0
sVGLAND FUNCTION
p258
F1.0
sVPERCENT
p259
F1.0
sVPROJECTED
p260
F-1.0
sVFREEZE
p261
F-1.0
sVGTP
p262
F3.0
sVREPORTED
p263
F4.0
sVINFESTATION
p264
F1.0
sVACTIVITY
p265
F1.0
sVLATIN SQUARE DESIGN
p266
F1.0
sVVEIN
p267
F2.0
sVPREVIOUS
p268
F3.0
sVMAMMALIAN
p269
F1.0
sVSQUAMOUS CELL
p270
F1.0
sVTARGET
p271
F1.0
sVESOPHAGEAL CARCINOMA
p272
F1.0
sVTHYROID GLAND
p273
F1.0
sVOCCASIONAL
p274
F1.0
sVKEY
p275
F0.0
sVHELA
p276
F3.0
sVITS
p277
F1.0
sVA549
p278
F3.0
sVCLIMATE
p279
F-1.0
sVDEGREE
p280
F1.0
sVNUCLEAR
p281
F3.0
sVTHYROXIN
p282
F1.0
sVTRIAL
p283
F1.0
sVBLACK
p284
F1.0
sVDURATION
p285
F-1.0
sVRAPIDLY
p286
F-1.0
sVEXPOSED
p287
F3.0
sVLOW
p288
F-1.0
sVINTERACT
p289
F1.0
sVNUMBER OF
p290
F3.0
sVP53 TUMOR SUPPRESSOR PROTEIN
p291
F1.0
sVSL2
p292
F1.0
sVENVIRONMENTAL
p293
F-1.0
sVB VIRUS
p294
F1.0
sVCLINICAL
p295
F1.0
sVCOMPONENTS
p296
F2.0
sVPROTEOMICS
p297
F3.0
sVERBB
p298
F1.0
sVDISTRIBUTIONS
p299
F1.0
sVAS A RESULT OF
p300
F1.0
sVSQUAMOUS CELL CARCINOMA
p301
F1.0
sVCHARACTERIZATION
p302
F1.0
sVBEAT
p303
F1.0
sVACTIVATION
p304
F3.0
sVSPECTRUM
p305
F1.0
sVDISPERSAL
p306
F1.0
sVRHAGOLETIS INDIFFERENS
p307
F1.0
sVCOMPUTER ASSISTED
p308
F1.0
sVGARLIC
p309
F1.0
sVTHYROID HORMONES
p310
F1.0
sVSERUM GLUCOSE
p311
F1.0
sVSTRAND
p312
F1.0
sVZONE
p313
F-1.0
sVGENES
p314
F3.0
sVEXCEPT FOR
p315
F1.0
sVE1B
p316
F3.0
sVBITTER
p317
F1.0
sVSERUM
p318
F2.0
sVTRANSCRIPTION FACTOR
p319
F1.0
sVTHYROID
p320
F1.0
sVCHEMORADIOTHERAPY
p321
F1.0
sVPREDICTIVE FACTOR
p322
F1.0
sVKOSOVO
p323
F1.0
sVBREED
p324
F1.0
sVUNCOMMON
p325
F1.0
sVCONSENSUS
p326
F3.0
sVSURVIVE
p327
F-1.0
sVREVEALED
p328
F1.0
sVMCF7 CELLS
p329
F3.0
sVHEPATOCELLULAR
p330
F1.0
sVPEPTIDE
p331
F3.0
sVLARVAE
p332
F1.0
sVENDED
p333
F1.0
sVADAPTION
p334
F-1.0
sVBINDING
p335
F4.0
sVGENERAL
p336
F1.0
sVLIVE
p337
F1.0
sVHORMONES
p338
F1.0
sVPINUS
p339
F0.0
sVPROTEIN
p340
F5.0
sVMETHOD
p341
F1.0
sVMOVEMENT
p342
F1.0
sVTHERMOGRAPHY
p343
F-1.0
sVRISK
p344
F0.0
sVDROSOPHILA
p345
F1.0
sVTUBULIN
p346
F3.0
sVBRIEF
p347
F-1.0
sVPAST
p348
F1.0
sVINDICATORS
p349
F1.0
sVSUPPLEMENTATION
p350
F1.0
sVINCREASING
p351
F0.0
sVPARTIAL
p352
F1.0
sVPATTERNS
p353
F3.0
sVFREQUENCY
p354
F1.0
sVINCLUDING
p355
F1.0
sVTRANSLATIONAL
p356
F3.0
sVUPTAKE
p357
F1.0
sVEXPERIMENTAL
p358
F0.0
sVINDEX
p359
F1.0
sVDEATH
p360
F3.0
sVFATTY ACIDS
p361
F1.0
sVINITIAL
p362
F1.0
sVMECHANISMS
p363
F0.0
sVLARGE
p364
F3.0
sVRATE
p365
F3.0
sVCOMPLEX
p366
F0.0
sVDESIGN
p367
F1.0
sVSTAINING
p368
F1.0
sVDYNAMICS
p369
F-1.0
sVDIPTERA
p370
F1.0
sVMAY BE
p371
F1.0
sVTRANSACTIVATION
p372
F1.0
sVFATTY
p373
F1.0
sVDEPENDENT
p374
F1.0
sVLEAVES
p375
F-1.0
sVRADIOIMMUNOASSAY
p376
F1.0
sVIONIZING RADIATION
p377
F1.0
sVCARRY
p378
F3.0
sVMALE
p379
F2.0
sVNUMEROUS
p380
F3.0
sVSURVIVAL
p381
F-1.0
sVSEMEN
p382
F1.0
sVEXPERIMENTAL EVIDENCE
p383
F-1.0
sVNON-
p384
F1.0
sVANGIOMYOLIPOMA
p385
F3.0
sVINFRARED THERMOGRAPHY
p386
F-1.0
sVEXTRACELLULAR
p387
F-1.0
sVALPINE
p388
F-1.0
sVPROVIDED
p389
F-1.0
sVBLOOD SERUM
p390
F1.0
sVNECK
p391
F1.0
sVPOSITIVE
p392
F1.0
sVTYPE 5
p393
F3.0
sVCROWNS
p394
F1.0
sVHUMAN CELLS
p395
F3.0
sVDIVERSE
p396
F-1.0
sVCOMPLICATED
p397
F1.0
sVMOL
p398
F3.0
sVSUMMER
p399
F1.0
sVTISSUES
p400
F-1.0
sVLIVER TISSUE
p401
F1.0
sVUSE
p402
F1.0
sVMARKERS
p403
F1.0
sVINFRARED
p404
F-1.0
sVCANCERS
p405
F1.0
sVHIGH RESOLUTION
p406
F-1.0
sVCOLLECTED
p407
F1.0
sVCASE
p408
F1.0
sVCASA
p409
F1.0
sVABILITY
p410
F0.0
sVHUMAN ADENOVIRUS TYPE 5
p411
F3.0
sVKDA
p412
F3.0
sVRELATED
p413
F-1.0
sVCHERRY
p414
F1.0
sVEXPRESSION
p415
F5.0
sVVIRAL
p416
F3.0
sVHAWTHORN
p417
F1.0
sVLOW RISK
p418
F-1.0
sVCAPTURE
p419
F1.0
sV466
p420
F3.0
sVCOVER
p421
F-1.0
sVFREE
p422
F1.0
sVRESISTANCE
p423
F-1.0
sVOBSERVED
p424
F5.0
sVABSENCE
p425
F3.0
sVCARRYING
p426
F3.0
sVMAJOR
p427
F3.0
sVWINTER
p428
F0.0
sVCOMPLICATED BY
p429
F1.0
sVSTRAND BREAKS
p430
F1.0
sVNOT DETECTED
p431
F1.0
sVRESULTS
p432
F3.0
sVTREES
p433
F0.0
sVANIMAL HUSBANDRY
p434
F1.0
sVCELL CYCLE
p435
F1.0
sVHUMAN BRUCELLOSIS
p436
F1.0
sVSTATISTICAL
p437
F1.0
sVEXPOSED TO
p438
F3.0
sVTYPE
p439
F3.0
sVPUBLIC
p440
F1.0
sVESOPHAGEAL SQUAMOUS CELL CARCINOMA
p441
F1.0
sVFEED
p442
F1.0
sVLOWER
p443
F4.0
sVELEMENTS
p444
F1.0
sVDIRECTLY
p445
F3.0
sVFINDINGS
p446
F-1.0
sVDID
p447
F3.0
sVPREMATURE
p448
F-1.0
sVDRY MATTER INTAKE
p449
F1.0
sVAIM
p450
F1.0
sVWASH
p451
F1.0
sVTHYROID FUNCTION
p452
F1.0
sVNEITHER
p453
F3.0
sVDIFFICULT
p454
F1.0
sVABSENT
p455
F3.0
sVNEFA
p456
F1.0
sVCALCULATION
p457
F1.0
sVPROTEINS
p458
F1.0
sVDEFICIENT
p459
F1.0
sVADENOVIRUS
p460
F3.0
sVFRUIT
p461
F1.0
sVIMMUNOHISTOCHEMICAL
p462
F2.0
sVTUMOR SUPPRESSOR PROTEIN
p463
F1.0
sVCELLS
p464
F8.0
sVMEAN
p465
F1.0
sVPCNA
p466
F1.0
sVPUBLIC HEALTH
p467
F1.0
sVFACTOR
p468
F2.0
sVEFFECT
p469
F2.0
sVE1B PROTEIN
p470
F3.0
sVHER-2
p471
F1.0
sVHEPATOCELLULAR CARCINOMA
p472
F1.0
sVALLOW
p473
F0.0
sVWOODY
p474
F-1.0
sVJUGULAR VEIN
p475
F1.0
sVPLANT
p476
F-1.0
sVMORE THAN
p477
F1.0
sVMONTHS
p478
F1.0
sVPINE
p479
F2.0
sVYEARS
p480
F2.0
sVPOLYMERIZATION
p481
F3.0
sVPROMISE
p482
F1.0
sVSIGNIFICANCE
p483
F1.0
sVIMPROVING
p484
F1.0
sVFLOWERS
p485
F-1.0
sVCONTINUED
p486
F1.0
sVRECOGNITION
p487
F3.0
sVCONCLUSION
p488
F1.0
sVDRY
p489
F1.0
sVREPAIR
p490
F1.0
sVGDP BINDING
p491
F3.0
sVESCAPE
p492
F-1.0
sVEIGHTY
p493
F3.0
sVSEMEN VOLUME
p494
F1.0
sVINHIBITION
p495
F1.0
sVHAVE
p496
F3.0
sVPROPER
p497
F1.0
sVGLUCOSE CONCENTRATION
p498
F1.0
sVRESPOND
p499
F1.0
sVELEVATION
p500
F-1.0
sVP70
p501
F1.0
sVPINUS SYLVESTRIS
p502
F1.0
sVKI-67
p503
F1.0
sVSPECIFIC
p504
F-1.0
sVHUMAN
p505
F5.0
sVRHAGOLETIS
p506
F1.0
sVTEMPERATURES
p507
F-1.0
sVUTILIZATION
p508
F1.0
sVPROVIDE
p509
F2.0
sVAMBIENT TEMPERATURE
p510
F1.0
sVGROWTH
p511
F1.0
sVDIAGNOSIS
p512
F3.0
sVYEAR
p513
F1.0
sVBALANCE
p514
F1.0
sVREDUCED
p515
F0.0
sVSIZE
p516
F1.0
sVLIMITED
p517
F-1.0
sVDOUBLE
p518
F1.0
sVVINBLASTINE
p519
F3.0
sVNEEDED
p520
F1.0
sVLEVELS
p521
F2.0
sVLIVER
p522
F1.0
sVMODIFICATION
p523
F3.0
sVCONCENTRATION
p524
F2.0
sVDISPERSE
p525
F1.0
sVFLY
p526
F1.0
sVBENEFICIAL
p527
F1.0
sVTREE
p528
F1.0
sVSUPPORT
p529
F1.0
sVDNA BINDING
p530
F1.0
sVCHOKE
p531
F1.0
sVTEPHRITIDAE
p532
F1.0
sVSERUM CHOLESTEROL
p533
F1.0
sVREPORT
p534
F3.0
sVBUBR1
p535
F3.0
sVNUTRITION
p536
F1.0
sVPOPULATIONS
p537
F3.0
sVQUANTIFY
p538
F1.0
sVRESEARCH
p539
F-1.0
sVREGULATION
p540
F1.0
sVPRODUCTION
p541
F1.0
sVWASHINGTON STATE
p542
F1.0
sVPARTUM
p543
F1.0
sVPONDEROSA PINE
p544
F1.0
sVTRI
p545
F1.0
sVSQUARE
p546
F1.0
sVDNA-PK COMPLEX
p547
F1.0
sVEXAMINED
p548
F1.0
sVPREGNANCY
p549
F1.0
sVMETABOLITES
p550
F1.0
sVLATIN
p551
F1.0
sVOLD
p552
F2.0
sVRESPONSE
p553
F2.0
sVGLUCOSE
p554
F1.0
sVPRODUCTIVITY
p555
F1.0
sVBUFFALOES
p556
F1.0
sVASSISTED
p557
F1.0
sVBOUND
p558
F3.0
sVPROMOTER
p559
F1.0
sVCONTROLLING
p560
F1.0
sVAMBIENT
p561
F1.0
sVTRANSGENICS
p562
F1.0
sVTFIIH
p563
F1.0
sVQUALITY
p564
F1.0
sVENDOGENOUS
p565
F1.0
sVSEASONAL
p566
F0.0
sVAPPLE
p567
F1.0
sVEVALUATE
p568
F2.0
sVRADIATION
p569
F2.0
sVCROSS
p570
F1.0
sVDEEP
p571
F1.0
sVIDENTIFIED
p572
F3.0
sVTHYROTROPIN
p573
F1.0
sVPROGRAM
p574
F3.0
sVCHOLESTEROL
p575
F1.0
sVPOST-TRANSLATIONAL MODIFICATION
p576
F3.0
sVNEU
p577
F1.0
sVSTUDIES
p578
F3.0
sVCAUSES
p579
F3.0
sVBRUCELLOSIS
p580
F1.0
sVETOPOSIDE
p581
F3.0
sVFROST
p582
F-1.0
sVTHROMBOSIS
p583
F1.0
sVENERGY BALANCE
p584
F1.0
sVLIVER CELLS
p585
F1.0
sVNUMBERS
p586
F1.0
sVDNA REPAIR
p587
F1.0
sVCLOSE
p588
F3.0
sVSPECTROMETRY
p589
F3.0
sVREPRODUCTIVE PERFORMANCE
p590
F1.0
sVDNA
p591
F6.0
sVDIET
p592
F1.0
sVUNCONTROLLED
p593
F1.0
sVRESPONSIVE
p594
F3.0
sVPROBLEM
p595
F1.0
sVSPERMATOZOA CONCENTRATION
p596
F1.0
sVGDP
p597
F3.0
sVRUMINANT
p598
F1.0
sVGREATER
p599
F-1.0
sVREPRODUCTIVE
p600
F0.0
sVLEG
p601
F1.0
sVORIENTED TOWARDS
p602
F1.0
sVSPERM
p603
F1.0
sVINTENSITY
p604
F-1.0
sVCLUMPED
p605
F1.0
sVC-ERBB-2
p606
F1.0
sVUSING
p607
F1.0
sVVEGETATIVE
p608
F-1.0
sVSCOTS PINE
p609
F1.0
sVPRUNUS AVIUM
p610
F1.0
sVUSA
p611
F1.0
sVNOT SIGNIFICANT
p612
F1.0
sVSTATE
p613
F1.0
sVNUMBER
p614
F3.0
sVEVIDENCE
p615
F0.0
sVHYPOTHESIS
p616
F1.0
sVGROUPS
p617
F1.0
sVNULL
p618
F3.0
sVCOEFFICIENT
p619
F1.0
sVCOMPARISON
p620
F1.0
sVEFFICACY
p621
F1.0
sVCONSTRAINT
p622
F1.0
sVESOPHAGEAL
p623
F1.0
sVERBB-2
p624
F1.0
sVRESOLUTION
p625
F-1.0
sVCYCLE
p626
F1.0
sVACIDS
p627
F1.0
sVRESULTING IN
p628
F-1.0
sVSEASON
p629
F2.0
sVVALUE
p630
F1.0
sVHOT
p631
F1.0
sVINVESTIGATION
p632
F1.0
sVBINDING SITE
p633
F3.0
sVNEARLY
p634
F1.0
sVMASS SPECTROMETRY
p635
F3.0
sVCORRELATION
p636
F1.0
sVTOLERANCE
p637
F-1.0
sVESSENTIAL
p638
F1.0
sVBLACK HAWTHORN
p639
F1.0
sVDEVELOPMENT
p640
F2.0
sVINCREASED
p641
F3.0
sVP53 TUMOR SUPPRESSOR
p642
F1.0
sVSELF
p643
F1.0
sVSNOW
p644
F-1.0
sVDEPENDENCY
p645
F1.0
s.